FDA Approves Orzeyful as First Targeted Treatment for Narcolepsy Type 1

The U.S. Food and Drug Administration has granted approval to Orzeyful tablets, marking a breakthrough medication that directly targets the underlying chemical loss causing narcolepsy type 1.

Loading lens…